Compounds > pomalidomide
Page last updated: 2024-09-04

pomalidomide and fludarabine

pomalidomide has been researched along with fludarabine in 2 studies

Compound Research Comparison

Studies
(pomalidomide)		Trials
(pomalidomide)		Recent Studies (post-2010)
(pomalidomide)		Studies
(fludarabine)		Trials
(fludarabine)		Recent Studies (post-2010) (fludarabine)
6231215523,4528121,415

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Rezende, LC; Guimarães, MC; Rangel, LB; Silva, IV1
Schmidt, C1

Reviews

1 review(s) available for pomalidomide and fludarabine

ArticleYear
Regulatory T cell as a target for cancer therapy.
    Archivum immunologiae et therapiae experimentalis, 2010, Volume: 58, Issue:3

    Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Humans; Immunotherapy; Lenalidomide; Mice; Models, Animal; Myeloablative Agonists; Neoplasms; T-Lymphocytes, Regulatory; Thalidomide; Vidarabine

2010

Other Studies

1 other study(ies) available for pomalidomide and fludarabine

ArticleYear
The struggle to do no harm in clinical trials.
    Nature, 2017, 12-21, Volume: 552, Issue:7685

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD19; Child; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Humans; Immunotherapy; Inflammation; Lenalidomide; Male; Neoplasms; Nivolumab; Prognosis; Programmed Cell Death 1 Receptor; Risk Management; T-Lymphocytes; Thalidomide; Treatment Outcome; Vidarabine

2017